# Bruker Corp: filings

BRKR · Nasdaq · CIK 1109354 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brkr.md) · [Financials](/companies/brkr/financials.md) · [Filings](/companies/brkr/filings.md) · [Insiders](/companies/brkr/insiders.md)

## Reports and events: 306 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 497, 8-K 206, SC 13G/A 60, 10-Q 53, 144 32, 3 31, 10-K 18, DEF 14A 18, SD 13, SCHEDULE 13G/A 12, 4/A 11, ARS 11, SC 13G 9, DEFA14A 8, UPLOAD 8, 8-K/A 4, CORRESP 4, S-8 4, 10-Q/A 3, 424B5 3, S-3ASR 3, SC 13D/A 3, 424B3 2, NT 10-K 2, SC TO-T/A 2, 10-K/A 1, 3/A 1, 5 1, 8-A12B 1, CERT 1, CT ORDER 1, D 1, DEFR14A 1, EFFECT 1, FWP 1, S-3 1, S-8 POS 1, SCHEDULE 13G 1, SC TO-C 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:05 ET | [8-K](/filings/0001193125-26-437771.md) | 8.01 Other events | 0001193125-26-437771 |
| 2026-08-14 | 16:15 ET | [8-K](/filings/0001193125-26-352279.md) | 8.01 Other events | 0001193125-26-352279 |
| 2026-08-05 | 16:24 ET | [10-Q](/filings/0001193125-26-335226.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335226 |
| 2026-08-04 | 07:00 ET | [8-K](/filings/0001193125-26-331511.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331511 |
| 2026-07-30 | 16:15 ET | [8-K](/filings/0001193125-26-326150.md) | 8.01 Other events | 0001193125-26-326150 |
| 2026-05-29 | 16:10 ET | [8-K/A](/filings/0001193125-26-248280.md) | 5.07 Shareholder vote results | 0001193125-26-248280 |
| 2026-05-21 | 16:44 ET | [8-K](/filings/0001193125-26-234630.md) | 5.07 Shareholder vote results | 0001193125-26-234630 |
| 2026-05-15 | 16:15 ET | [8-K](/filings/0001193125-26-226767.md) | 8.01 Other events | 0001193125-26-226767 |
| 2026-05-07 | 16:09 ET | [10-Q](/filings/0001193125-26-211889.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211889 |
| 2026-05-06 | 06:30 ET | [8-K](/filings/0001193125-26-207498.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-207498 |
| 2026-04-28 | 16:16 ET | [8-K](/filings/0001193125-26-187102.md) | 8.01 Other events | 0001193125-26-187102 |
| 2026-04-10 | 16:17 ET | [DEF 14A](/filings/0001193125-26-151305.md) | Proxy statement, period 2026-05-21 | 0001193125-26-151305 |
| 2026-04-10 | 16:02 ET | [8-K](/filings/0001193125-26-151220.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-151220 |
| 2026-04-01 | 07:00 ET | [8-K](/filings/0001193125-26-135660.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-135660 |
| 2026-02-27 | 16:04 ET | [10-K](/filings/0001193125-26-082523.md) | Annual report, period 2025-12-31 | 0001193125-26-082523 |
| 2026-02-20 | 16:38 ET | [8-K](/filings/0001193125-26-061500.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-26-061500 |
| 2026-02-12 | 07:00 ET | [8-K](/filings/0001193125-26-047618.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-047618 |
| 2026-01-12 | 12:00 ET | [8-K](/filings/0001193125-26-010106.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-26-010106 |
| 2025-12-09 | 10:10 ET | [8-K](/filings/0001193125-25-312106.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-312106 |
| 2025-11-05 | 16:30 ET | [10-Q](/filings/0001193125-25-267049.md) | Quarterly report, period 2025-09-30 | 0001193125-25-267049 |
| 2025-11-03 | 07:00 ET | [8-K](/filings/0001193125-25-261638.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-261638 |
| 2025-09-08 | 16:21 ET | [8-K](/filings/0001140361-25-034295.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-034295 |
| 2025-08-06 | 19:05 ET | [10-Q](/filings/0000950170-25-103333.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103333 |
| 2025-08-04 | 07:00 ET | [8-K](/filings/0000950170-25-101605.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-101605 |
| 2025-07-21 | 08:00 ET | [8-K](/filings/0000950170-25-097082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-097082 |
| 2025-05-29 | 16:34 ET | [8-K](/filings/0000950170-25-079029.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-079029 |
| 2025-05-14 | 16:03 ET | [8-K](/filings/0000950170-25-071353.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-071353 |
| 2025-05-07 | 16:04 ET | [10-Q](/filings/0000950170-25-065610.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065610 |
| 2025-05-07 | 07:00 ET | [8-K](/filings/0000950170-25-064973.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064973 |
| 2025-04-11 | 16:28 ET | [DEF 14A](/filings/0000950170-25-053286.md) | Proxy statement, period 2025-05-29 | 0000950170-25-053286 |
| 2025-04-11 | 08:00 ET | [8-K](/filings/0000950170-25-053032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-053032 |
| 2025-03-03 | 16:27 ET | [10-K](/filings/0000950170-25-030897.md) | Annual report, period 2024-12-31 | 0000950170-25-030897 |
| 2025-02-21 | 08:00 ET | [8-K](/filings/0000950170-25-024543.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-024543 |
| 2025-02-13 | 07:00 ET | [8-K](/filings/0000950170-25-019332.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-019332 |
| 2025-01-16 | 17:10 ET | [8-K](/filings/0000950170-25-006262.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-006262 |
| 2025-01-13 | 11:06 ET | [8-K](/filings/0000950170-25-004646.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000950170-25-004646 |
| 2024-11-07 | 16:06 ET | [10-Q](/filings/0000950170-24-123298.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123298 |
| 2024-11-05 | 07:00 ET | [8-K](/filings/0000950170-24-121064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-121064 |
| 2024-08-09 | 16:41 ET | [10-Q](/filings/0000950170-24-094832.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094832 |
| 2024-08-07 | 08:30 ET | [8-K](/filings/0001104659-24-086565.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-086565 |
| 2024-08-06 | 07:00 ET | [8-K](/filings/0000950170-24-091188.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091188 |
| 2024-06-05 | 16:30 ET | [8-K/A](/filings/0001104659-24-068698.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068698 |
| 2024-05-31 | 16:10 ET | [8-K](/filings/0001104659-24-067154.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067154 |
| 2024-05-30 | 15:23 ET | [8-K](/filings/0000950170-24-066508.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0000950170-24-066508 |
| 2024-05-10 | 15:29 ET | [10-Q](/filings/0000950170-24-057736.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057736 |
| 2024-05-02 | 07:00 ET | [8-K](/filings/0000950170-24-051560.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-051560 |
| 2024-05-02 | 07:00 ET | [8-K](/filings/0000950170-24-051559.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-051559 |
| 2024-04-22 | 07:16 ET | [8-K](/filings/0001104659-24-049697.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-049697 |
| 2024-04-19 | 16:34 ET | [DEF 14A](/filings/0000950170-24-046045.md) | Proxy statement, period 2024-05-30 | 0000950170-24-046045 |
| 2024-04-02 | 09:28 ET | [8-K](/filings/0000950170-24-039776.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-039776 |

Page 1 of 7. [Older](/companies/brkr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:07 ET. No prices; not investment advice.